Massachusetts Life Science Center
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion initiative that was signed into law in June of 2008. The MLSC’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community.Read More
Triumvirate Environmental Inc. (Founding Sponsor) is a leading provider of waste management, environmental field services, and EH&S technical service for life science and biotech organizations throughout the United States.
Triumvirate’s broad service line includes comprehensive hazardous waste management, lab packing, EH&S compliance consulting and reporting, chemical lab moves, EH&S training, and a variety of other solutions aimed at providing safe, compliant, and sustainable working environments for organizations in the life sciences, industrial, healthcare, and education markets. With a focus on innovative, customer-intimate solutions, Triumvirate has remained a premier environmental, health, and safety provider for 25 years.Read More
Johnson & Johnson Innovation
Johnson & Johnson Innovation, LLC focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of innovations to solve unmet needs in patients. Through a collaboration with Johnson & Johnson Innovation and LabCentral, JLABS @LabCentral has been established at the LabCentral facility in the Kendall Square biotech hub. JLABS @LabCentral marks the first East Coast expansion for JLABS, which will operate with the same open-innovation, no-strings attached approach as it does at the flagship JLABS in San Diego. As a Founding Sponsor of LabCentral, Johnson & Johnson Innovation will select a few high-potential innovators for the shared-laboratory space who are focused on promising science that addresses important unmet medical needs.Read More
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. In 2013 the Roche Group employed over 85,000 people worldwide, invested 8.7 billion Swiss francs in R&D and posted sales of 46.8 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.Read More
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2incubators, shakers, and cell manipulation systems. Associated consumables like pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the instruments for highest quality workflow solutions.
Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance.
Our customers in labs all over the world constantly expect more of their working environment. They don´t just buy products; they buy elements of their daily lab work, and they demand products that can help them live up to today´s priorities in the lab.That means for Eppendorf, that we bundle all our know-how and focus it on the needs of our customers. The Eppendorf brand represents a unique world that sets itself apart from other brands and shows us in a particular light.Read More
Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in Emerging Markets, are currently fueling the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries.Read More
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
One of the pioneers in biotechnology, Biogen today has the leading portfolio of medicines to treat multiple sclerosis (MS), has the first and only approved treatment for spinal muscular atrophy (SMA) and is at the forefront of research into new medicines for neurological and neurodegenerative conditions. Led by world-class research and development, Biogen uses novel science and leading-edge technologies to create, commercialize, and manufacture transformative therapies for patients with few or no treatment options.
It is our belief that no other area of medicine holds as much promise with as much need as neuroscience. With our foundation of almost four decades of expertise in neurology, we aim to be the leader in this area by developing transformational therapies to address what we believe are becoming the world’s most significant unmet medical needs.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis C, HIV and rheumatoid arthritis. The Bristol Myers Squibb Foundation’s philanthropic programs seek to promote health equity and improve the health outcomes among populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
Locke Lord LLP
Locke Lord understands the extraordinary passion that innovators bring to their ideas and the need to build value quickly. From incorporation through important milestones, we strive to create value by providing superior legal advice and business counsel to protect and advance the interests of our clients. Locke Lord is a full-service, international law firm that ranks among The American Lawyer’s top U.S. law firms. Our team of approximately 1,000 lawyers has earned a solid reputation in their work in private equity, venture capital, life sciences and biotech, corporate and finance, complex litigation, insurance and reinsurance and intellectual property.
New England BioLabs
New England Biolabs, Inc. leads the industry in the discovery and production of enzymes for molecular biology applications, including sample preparation for next-generation sequencing. NEB’s global reputation for manufacturing products of the highest quality, coupled with best-in-class technical support, makes NEB the first choice for optimized reagents for advanced technologies.
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases. Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity.Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries and markets its products in more than 170 countries. Locally, Novo Nordisk has opened a new site in Cambridge, MA with business development, alliance management, search and evaluation, and external innovation sourcing.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Working together for a healthier world®
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio.
Established in 1997, BioMarin is a California-based, global biotechnology company that is committed to the translation of genetic discoveries into transformative medicines. We do this by focusing on diseases with precisely understood mechanisms that are rooted in GENETICS, developing TARGETED therapeutic interventions that address the underlying cause of disease, utilizing readily ASSESSABLE endpoints that are proximal to the disease pathway, and enabling TRANSFORMATIONAL changes to the way patients feel, function, and survive.
Gunderson Dettmer represents more than 2500 of the world’s most dynamic emerging growth companies from start-up to maturity, and more than 250 of the world’s most impactful venture capital firms.
We are singularly focused on serving the legal needs of the emerging company marketplace. We advise our clients on a broad range of startup, governance, financing, intellectual property, corporate partnering and M&A matters. Our life sciences group focuses exclusively on the representation of a wide range of companies in the life science sector, including biotechnology, bioinformatics, healthcare IT, pharmaceuticals and medical devices and diagnostics. Recognized as the most active venture capital law firm in the world, we are uniquely qualified to help entrepreneurs and their stakeholders achieve their goals.
The LG Chem Life Sciences Innovation Center was founded to globalize LG Chem biotechnology and R&D capabilities. LG Chem’s R&D expertise in partnership with local academic institutions and biotech companies will bring innovative therapeutics to patients worldwide. The company focuses on oncology, immune-oncology, and metabolic disease areas. Working at the forefront of novel platforms, targets, and approaches to redefining the development of new medicines and bringing healthcare into the digital age. The LG brand brings together life sciences, electronics, and world class information technology to create a cluster of expertise that adds value across the healthcare value chain.
Lilly is a global healthcare leader that unites caring with discovery to improve the lives of millions of patients around the world. We were founded almost 150 years ago by a man committed to creating high-quality medicines that meet profound medical needs, and today we remain true to that mission. Across the globe, Lilly employees strive to discover and provide life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. Lilly seeks to lead in areas of unmet medical need across our therapeutic areas of diabetes, neurodegeneration, pain, immunology, and oncology. Our local presence has continued to grow since 2015 with the recent colocalization of business development, search and evaluation, and internal R&D teams at the Lilly Cambridge Innovation Center located in the heart of Kendall Square.
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA of Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of €12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.
Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark “Merck” internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Novartis Institutes for BioMedical Research (NIBR) is the global drug discovery network for Novartis. NIBR is headquartered in Cambridge, MA, USA. NIBR is comprised of more than 6,000 scientists, physicians, and business professionals working together across nine campuses around the world – Cambridge, MA, East Hanover, NJ, San Diego, CA, and Emeryville, CA in the USA; Basel, Switzerland, Siena, Italy, and Horsham, UK in Europe; Shanghai, China and Singapore in Asia. Committed to discovering new medicines to help patients with high unmet medical need, we work to push the boundaries of science. We are proud of our open, collaborative, and dynamic work environment that supports a team approach to scientific discovery. At NIBR, team members can be across the hall or across the ocean. We offer a variety of opportunities for professional growth and development to foster a culture that values diversity, collaboration, and great science.
Since its foundation in 1717, Ono Pharmaceutical Co., Ltd., headquartered in Osaka Japan, has been working for people's health and devotes all its efforts to drug discovery to accomplish delivering new drugs to the world with a wish.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life science, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 15,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally.
With a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings. Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification. For over 35 years, Promega has consistently integrated the values of corporate responsibility and sustainable business practices into all aspects of our corporate culture and activity. We realize that our success depends upon the connections we forge among our customers, community and employees.
Servier is a global pharmaceutical company headquartered in France and governed by a non-profit foundation with a presence in about 150 countries and a revenue of $4.6 billion dollars in 2018. We are focused on growth and innovation in five key therapeutic categories: oncology, cardiology, immuno-inflammatory, neuroscience and metabolism. Globally, we’re committed to establishing our leadership in oncology, with a goal to invest 50 percent of our R&D efforts into the therapeutic area. Being a privately held company allows us the freedom to do what many of our publicly traded bio-pharmaceutical peers can’t – devote our energy toward putting patients and caregivers first. In fact, Servier reinvests 25 percent of its total revenue (excluding generic drugs) to research and development for the benefit of patients. A considerable portion of our R&D investment goes to fighting cancer and addressing critical unmet patient needs, helping us strive toward our goal of creating a world for future generations where quality healthcare is available and accessible to all.
VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global provider of laboratory supplies, equipment and services with worldwide sales in excess of $4.1 billion in 2012. VWR enables the advancement of the world’s most critical research by providing product and service solutions to laboratories and production facilities in the pharmaceutical, biotech, industrial, educational, governmental and healthcare industries. With over 160 years of industry experience, VWR offers a well-established network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way scientists, researchers, medical professionals and engineers across the Americas, Europe and Asia Pacific stock and maintain their facilities. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.
ZEISS Research Microscopy Solutions (RMS)
ZEISS Research Microscopy Solutions (RMS) is the world’s one-stop manufacturer of light, electron, X-ray and ion microscope systems and software that offers solutions for Biopharma and Biotech Scientists. ZEISS has the most powerful portfolio of innovative technologies including automated workflows, multiplex microscopy solutions, machine learning, lab documentation, as well as cost-efficient image analysis in the cloud.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
BioIT Solutions delivers highly effective data management and workflow systems ready-made for today’s fast paced life science laboratories. We apply our decades of experience in the biopharmaceutical industry with our flexible 1PLATFORM4® Software Suite to engineer rapidly-deployed and customized solutions in a cost-effective manner. With BioIT Solutions, your scientific data are safely managed by a logical, consistent and responsive system designed to be:
- Adaptable to meet the demands of new technology and evolving business needs
- Interoperable to link data from instruments, partners and other systems
- Traceable to visualize relationships between materials, experimental parameters and results
- Tailored to collect and present data for various stakeholders
BioIT Solutions is the information technology partner for LabCentral and CCRCT’s COVID-19 testing efforts. We built the mobile application that collects sampling data and images, and the lab system that prints kit labels, processes samples, captures test measurements, and reports results.
For more information or a demo, please contact us at email@example.com or visit our website at www.bioit.com.
Elemental Machines is accelerating scientific discovery with intelligent technology for the smart lab that gives researchers a fast, easy and cost-effective way to monitor invisible environmental variables. With cloud-based software and a portfolio of connected devices, the EM Suite collects and visualizes critical environmental data (ambient temperature, humidity, vibration, CO2 levels, and more), and uses advanced analytics to provide valuable insights into the factors contributing to test outcomes. Researchers can access data anytime, anywhere, and receive real-time alerts should any of the intelligent sensors detect an issue or abnormal data pattern. With offices in Cambridge, MA and Burlingame, CA the company is committed to addressing some of the scientific community’s biggest challenges.
Goodwin Procter LLP is a leading Am Law 50 and Global 50 law firm, with offices across the United States, Europe and Asia. Our 900 plus lawyers excel at complex transactions, high-stakes litigations and world-class advisory services in the life sciences, private equity, technology, real estate, and financial services industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. Goodwin has one of the leading life sciences practices in the United States. We offer a full-service team of 100+ lawyers serving 400+ life sciences clients. We provide industry expertise that is built to serve all legal needs of life sciences clients including corporate, partnering, regulatory, intellectual property and litigation.
LI-COR® Biosciences is a leading manufacturer of near-infrared and chemiluminescent imaging platforms, analysis software, and IRDye® infrared dye reagents for quantitative Western Blotting, small animal imaging, and DNA fragment analysis. LI-COR pioneered the development of near-infrared fluorescence detection systems for DNA sequencing, and today provides systems for drug discovery, protein research, small animal imaging, and undergraduate training.
Founded in 1971, the privately held company is based in Lincoln, Nebraska, with subsidiaries in Germany and the United Kingdom. LI-COR systems are used in over 100 countries and are supported by a global network of distributors.
Meso Scale Diagnostics
Founded in 1995, Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples. MSD’s proprietary MULTI‑ARRAY technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance. MSD’s technology has been widely adopted by researchers in pharmaceutical companies, government institutions, universities, and clinical laboratories worldwide for its high sensitivity, excellent reproducibility, and wide dynamic range. Throughout its history, MSD has continued to evolve its technology platform to enable researchers to solve complex biological questions and, as the Company looks toward the future, it is expanding into clinical applications and the emerging fields of personalized medicine and companion diagnostics.
Our mission at NanoTemper Technologies is to create biophysical tools for scientists in drug discovery and development who need to tackle challenging characterizations. Working with scientists striving to make a difference in the world gets us excited. If you’re facing challenges with affinity screening, molecular interactions, protein stability, protein expression, or protein quality, let’s talk.
Newmark Knight Frank
Newmark Knight Frank is the premiere commercial real estate firm advising life science companies ranging from start-ups to global pharmaceuticals on real estate strategy in the Cambridge area. With a focus on office and laboratory leasing, consulting and project management, the Cambridge Newmark team has provided expertise to many of the area’s most exciting firms. Newmark ensures the best possible real estate solution with the goal of advancing the client’s science or technology.
Founded in 1929 Newmark now has 400 offices across the globe.
Headquartered in Lawrence, MA, Nexcelom Bioscience LLC is a manufacturer of innovative Cellometer®, Cellaca™ MX, and Celigo® image cytometry products for cell counting and analysis. Nexcelom's solutions automate time-consuming procedures and offer innovative solutions, enabling scientists to focus less on the process and more on the research results. Visit us to learn more at www.nexcelom.com.
At Evident, we are guided by the scientific spirit—innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.
Evident Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of clinical research, educational, and premium microscopes and microscope systems.
Founded in 2001, Steady Vision is an interactive services provider focused on all aspects of Web design & development:
- Mobile/Email Marketing/Social Media
At Steady Vision, we’re passionate about delivering the most creative and effective solutions possible, on time and in budget. Our solutions are flexible and scalable, allowing our clients to identify, harness and leverage change to produce competitive advantage. The cornerstone of our success is our capacity to understand client needs, streamlining marketing objectives and bringing them to life through a uniform application across all forms of media. We are committed to building long-lasting relationships and providing continual value by identifying new and diverse ways to improve and expand upon your successes online.
Union Office Interiors
Since 1966, Union Office Interiors has been building long term relationships grounded in collaboration and communication. As your trusted furniture partner, we help bring your design & vision to life. Delivering outstanding results through exceptional service.